Main Content

Webinars, Conferences, and Discussions

Filter by:

No webinars found.

Our Archived sessions

Wed 09 September 2026
SFA Childhood Cancer Subtype Series: Ewing Sarcoma
In recognition of Childhood Cancer Awareness Month, join us for the next installment of our Subtype Series, exploring Ewing sarcoma from three complementary perspectives: clinical care, emerging research, and the patient and caregiver experience. The discussion will cover how Ewing sarcoma is diagnosed and treated; how Ewing sarcoma biology, biomarkers, disease monitoring, and emerging therapies are shaping the future of treatment; and the experiences of patients and families throughout diagnosis, treatment, recurrence, and survivorship.
Fri 17 July 2026
Advocacy Weekend 2026: Education Day
View our recorded educational sessions from Education Day, a part of Sarcoma Community Advocacy Weekend in Washington, D.C., held during Sarcoma Awareness Month on July 17, 2026, featuring sessions focused on drug development and advocacy.
Wed 16 September 2026
Webinar: How to Talk to Kids About Rare Cancers
Join SFA in collaboration with Pickles Group for a free one-hour live webinar and parent panel focused on the unique experiences of families navigating rare cancers while parenting. Although each rare cancer diagnosis is uncommon, rare cancers collectively make up about 25% of all cancer diagnoses, meaning many families are facing a path that can feel unfamiliar and hard to find support around. This webinar is well suited for parents, caregivers, friends, family, and professionals.
Wed 23 September 2026
Pediatric Series: Clinical Trial Access — Why Children with Cancer Often Lack Clinical Trial Options
In recognition of Childhood Cancer Awareness Month, join the Sarcoma Foundation of America for a one-hour webinar exploring why children and adolescents with cancer often have fewer clinical trial opportunities than adults, particularly those with rare cancers such as sarcoma. This webinar will explore why these gaps exist, how changes in pediatric drug development and more age-inclusive clinical trial design are expanding opportunities, and what families can do to identify and access appropriate clinical trials.
Wed 24 June 2026
SFA Subtype Series: Understanding Angiosarcoma
Join us for the next installment of our Subtype Series, focused on angiosarcoma, a rare and often aggressive sarcoma that arises from the cells lining blood vessels and lymphatic vessels. This educational webinar will provide an overview of angiosarcoma, including how it is diagnosed, current treatment approaches, emerging research, and clinical trial opportunities. Participants will also learn about ongoing efforts to improve outcomes for patients through collaborative research and patient advocacy initiatives. Our featured speakers are Dr. Silvia Stacchiotti, one of the world’s leading sarcoma medical oncologists and an internationally recognized expert in angiosarcoma from Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy and President of the Italian Sarcoma Group; Dr. Lee Cranmer, Chief of Sarcoma Medical Oncology at City of Hope and a leading expert in sarcoma clinical care and clinical trials; and Dr. Corrie Painter, researcher, patient advocate, and founder of the Angiosarcoma Project.
Fri 24 April 2026
Understanding Biomarkers in Sarcoma: How Testing Can Guide Treatment and Trial Options
Join us for the next Live Virtual Session with the Experts! This session will provide an overview of biomarkers, what they are and how they are discovered and validated. During the session we will highlight the different types of biomarker tests used in sarcoma, how results are interpreted, and how this information can guide personalized treatment strategies. As biomarker testing becomes more integrated into patient care, understanding biomarkers and how they can be used in treatment planning can help patients and families better navigate their treatment and clinical trial options. Our expert speakers, Dr. Sandra D’Angelo (Sarcoma Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY) and Dr. Priya Chudasama (Precision Sarcoma Research, German Cancer Research Center, Heidelberg, Germany), will provide both clinical and research perspectives on how biomarker testing is used today and where the field is heading.
Wed 25 March 2026
ctDNA in Sarcomas: Advancing the Conversation
We invite you to join us for Part 2 of our educational webinar series on circulating tumor DNA (ctDNA) in sarcomas. Building on our foundational session, An Introduction to ctDNA in Sarcoma, this next installment moves the conversation forward—addressing emerging research, practical considerations, and the real-world questions patients and clinicians are navigating today. Submit any questions you have in advance or use the Q&A feature during the event.
Thu 10 April 2025
SFA Subtype Series: Chondrosarcoma Webinar
Wed 25 June 2025
SFA Subtype Series: PEComa Webinar
Mon 08 September 2025
Sarcoma Diagnosis Webinar
ribbon

Make a Donation

Help us move closer to a world where people do not die from sarcoma

Make a Donation
ribbon

section